Torrent Pharma will acquire a 46.39% stake in JB Chemicals for ₹11,917 crore from KKR, followed by a merger and open offer. The deal boosts Torrent's domestic presence, adds new therapeutic segments, and enhances global scale. JB Pharma's strong financials and market position make it a strategic fit for Torrent.